Simulations Plus closes USD 376.8 million take-private merger
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Simulations Plus completed a USD 376.8 million merger, going private and delisting from Nasdaq. Shareholders received USD 18.50 per share in cash, and the company is now a wholly owned subsidiary of an Altaris affiliate. It continues model-informed drug development, pharmacometrics, toxicology and AI-enabled drug design, combined with Chemical Computing Group.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.